<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>146(5)</volume><submitter>Leyden S</submitter><funding>Neuroendocrine Tumor Research Foundation</funding><pubmed_abstract>Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33-37 questions (depending on type of respondent) across four areas: information, care, treatments and research. In total, 443 participants from 26 countries responded: 338 patients/families, 35 advocates and 70 HCPs. Perceived unmet needs regarding provision of information at diagnosis differed between groups. While 59% of HCPs believed they provided sufficient information, informational needs were mostly/fully met for only 30% of patients and 18% of advocates. Addit</pubmed_abstract><journal>International journal of cancer</journal><pagination>1316-1323</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7004101</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.</pubmed_title><pmcid>PMC7004101</pmcid><pubmed_authors>Wiedenmann B</pubmed_authors><pubmed_authors>Caplin M</pubmed_authors><pubmed_authors>Hicks RJ</pubmed_authors><pubmed_authors>Hollander R</pubmed_authors><pubmed_authors>Goldstein G</pubmed_authors><pubmed_authors>O'Toole D</pubmed_authors><pubmed_authors>International Neuroendocrine Cancer Alliance (INCA)</pubmed_authors><pubmed_authors>Fisher G</pubmed_authors><pubmed_authors>Falconi M</pubmed_authors><pubmed_authors>Davies P</pubmed_authors><pubmed_authors>Kolarova T</pubmed_authors><pubmed_authors>Metz DC</pubmed_authors><pubmed_authors>Majima Y</pubmed_authors><pubmed_authors>Ferolla P</pubmed_authors><pubmed_authors>Bouvier C</pubmed_authors><pubmed_authors>Leyden S</pubmed_authors><pubmed_authors>Dureja S</pubmed_authors><pubmed_authors>Lawrence B</pubmed_authors><pubmed_authors>Ruszniewski P</pubmed_authors><pubmed_authors>Conroy S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.</name><description>Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33-37 questions (depending on type of respondent) across four areas: information, care, treatments and research. In total, 443 participants from 26 countries responded: 338 patients/families, 35 advocates and 70 HCPs. Perceived unmet needs regarding provision of information at diagnosis differed between groups. While 59% of HCPs believed they provided sufficient information, informational needs were mostly/fully met for only 30% of patients and 18% of advocates. Addit</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Mar</publication><modification>2025-04-18T17:59:22.927Z</modification><creation>2020-05-22T09:54:41Z</creation></dates><accession>S-EPMC7004101</accession><cross_references><pubmed>31509608</pubmed><doi>10.1002/ijc.32678</doi></cross_references></HashMap>